<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>Cell recovery under antiretroviral therapy</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Cell recovery under antiretroviral
therapy</h1>



<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>For the second quarter of 2023, it is estimated that 125,527 people
living with human immunodeficiency virus (HIV) are on antiretroviral
treatment with active status, according to the Secretary of Health in
Mexico. CD4 T cells percentages at different times have been
consistently identified as correlates of CD4 T cell recovery. CD4 T cell
proportions, along with other accessible variables, could serve as
predictors for the immunological response to antiretroviral therapy
(ART) in patients with advanced HIV infection.</p>
<p>To create accessible variables for predictors of CD4 T cell recovery
and viral load, the <code>tidyverse</code> suite can be used for data
transformation, and the <code>viraldomain</code> package can be used to
access CD4 counts and viral load data. The goal is to calculate recovery
rates for each consecutive year, taking both 2019 and 2021 as basal
counts, considering one year and two year change rates.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="fu">library</span>(tidyverse)</span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a><span class="fu">library</span>(viraldomain)</span>
<span id="cb1-3"><a href="#cb1-3" tabindex="-1"></a><span class="fu">data</span>(viral, <span class="at">package =</span> <span class="st">&quot;viraldomain&quot;</span>)</span>
<span id="cb1-4"><a href="#cb1-4" tabindex="-1"></a>recovery_rates <span class="ot">&lt;-</span> viral <span class="sc">|&gt;</span></span>
<span id="cb1-5"><a href="#cb1-5" tabindex="-1"></a>  <span class="fu">mutate</span>(</span>
<span id="cb1-6"><a href="#cb1-6" tabindex="-1"></a>    <span class="at">recovery_rate_2021 =</span> (cd_2021 <span class="sc">-</span> cd_2019) <span class="sc">/</span> cd_2019,</span>
<span id="cb1-7"><a href="#cb1-7" tabindex="-1"></a>    <span class="at">recovery_rate_2022 =</span> (cd_2022 <span class="sc">-</span> cd_2021) <span class="sc">/</span> cd_2021,</span>
<span id="cb1-8"><a href="#cb1-8" tabindex="-1"></a>    <span class="at">recovery_rate_2022_2yr =</span> (cd_2022 <span class="sc">-</span> cd_2019) <span class="sc">/</span> cd_2019,</span>
<span id="cb1-9"><a href="#cb1-9" tabindex="-1"></a>    <span class="at">viral_rate_2021 =</span> (vl_2021 <span class="sc">-</span> vl_2019) <span class="sc">/</span> (vl_2019<span class="sc">+</span><span class="dv">1</span>),</span>
<span id="cb1-10"><a href="#cb1-10" tabindex="-1"></a>    <span class="at">viral_rate_2022 =</span> (vl_2022 <span class="sc">-</span> vl_2021) <span class="sc">/</span> (vl_2021<span class="sc">+</span><span class="dv">1</span>),</span>
<span id="cb1-11"><a href="#cb1-11" tabindex="-1"></a>    <span class="at">viral_rate_2022_2yr =</span> (vl_2022 <span class="sc">-</span> vl_2019) <span class="sc">/</span> (vl_2019<span class="sc">+</span><span class="dv">1</span>)</span>
<span id="cb1-12"><a href="#cb1-12" tabindex="-1"></a>  )</span></code></pre></div>
</div>
<div id="patient-data" class="section level1">
<h1>Patient data</h1>
<p>Data processing followed 35 patients under ART during three years:
2019, 2021 and 2022. Twenty two patients had reached undetectable viral
load (VL) by year 2022, and had available CD4 T cell counts at each
year. Data were obtained from routine laboratory tests of HIV treatment
follow-up.</p>
<div class="float">
<img src="data:image/png;base64,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" alt="Cohort’s response to ART from 2019 to 2022. A, Viral load (HIV RNA copies/mL blood). B, CD4 T cell count (cells/mm3 blood)" />
<div class="figcaption">Cohort’s response to ART from 2019 to 2022. A,
Viral load (HIV RNA copies/mL blood). B, CD4 T cell count (cells/mm3
blood)</div>
</div>
<p>Figure 1 A shows viral loads in 2019 have a range from 0 to 38961,
with a median of 93. In 2021, there is a notable increase in viral
loads, with a median of 262 and a maximum of 516675. Viral loads in 2022
show a similar pattern to 2021, with some patients having high
values.</p>
<p>The majority of patients had non-zero viral loads in 2019, with a
wide range. In 2021, there is a substantial increase in viral loads for
several patients. Viral loads in 2022 show variability, with the mean
behavior achieving undetectable viral load and many patients showing low
values and few others showing persistence with previous years, though
these values act as outliers and they could be due to random noise in
the cohort since they belong to patients with viral loads higher than
average.</p>
<p>In Figure 1 B, the median CD4 count in 2019 is 494, showing a central
tendency. In 2021, the median CD4 count is 454, indicating relatively
stable counts compared to 2019. The median CD4 count in 2022 is 547,
showing a potential increase compared to 2021.</p>
<p>One patient stands out with a remarkably high CD4 count of 1960 in
2021, potentially indicating a unique response to treatment. Only two
patients maintain relatively stable CD4 counts over the observed years,
one patient experiences a significant drop in CD4 count from 2021 to
2022, but the rest of the cohort shows a cell count increase.</p>
<div class="float">
<img src="data:image/png;base64,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" alt="Patterns of HIV Viral Dynamics in Response to Treatment. A, Viral Load Change Rates Across Years. B, Longitudinal Analysis of CD4 T Cell Recovery Rates Over Time." />
<div class="figcaption">Patterns of HIV Viral Dynamics in Response to
Treatment. A, Viral Load Change Rates Across Years. B, Longitudinal
Analysis of CD4 T Cell Recovery Rates Over Time.</div>
</div>
<p>Now, Figure 2 A displays the viral change rates, exhibiting diverse
patterns across patients. Notable variations are observed in the 1-year
and 2-year differences. The longitudinal trends for the 2021 viral rates
show a range from -0.99 to 49248.00, indicating significant variability.
The majority of values are negative, with some extreme positive values,
indicating a stabilization towards undetectable load but with some
persistence on viral activity. The 2022 viral rate ranges from -0.9999
to 79.5529, showcasing a diminished spectrum. Positive values indicate
an increase, while negative values suggest a decrease, with the mean
behavior pointing towards an overall decrease in rates. The 2022 viral
rate with a 2-Year difference also exhibits a wide range from -1.00 to
49248.00, emphasizing the impact of longer-term changes. Notable
positive and negative values reflect diverse responses. Seasonality
shows some patients with consistent trends over the short term, while
others exhibit fluctuations over a more extended period. Short-term
seasonality is evident in rapid changes, while long-term patterns vary
widely. Extreme values, such as 49248.00, may indicate outliers or
specific responses to treatment interventions and potential influencing
factors.</p>
<p>In Figure 2 B, CD4 T cell count recovery rates show a range of
positive and negative values, showing a substantial variability is
observed across patients, reflecting diverse responses to treatment. The
longitudinal trend for the 2021 recovery rate ranges from -0.70250 to
2.52518, both positive and negative values indicate varying rates of
improvement or decline. The 2022 recovery rate ranges from -0.61631 to
1.27523. The mean suggests an overall positive trend, with more patients
experiencing improvement. The 2022 recovery rate with a 2-Year
difference presents a range from -0.628655 to 0.741935, emphasizing
longer-term changes. The mean is close to zero, suggesting a stabilizing
effect over the two-year period. Short-term fluctuations in recovery
rates may be indicative of response variations to ART interventions.
Long-term stability, as indicated by the mean of the 2-year recovery
rate, suggests a potential stabilizing effect of ART.</p>
<p>The effect on the mean recovery rate for 2022 (2-Year) being close to
zero may indicate a stabilizing effect of ART on CD4 T cell counts over
a longer duration. THe majority of patients show consistent positive
recovery trends, while others exhibit fluctuations. Extreme positive
values indicate a substantial increase in cell recovery, which can be
considered beneficial for overall health. These high positive values
suggest a significant improvement in CD4 T cell counts for the
corresponding patients. Patients with recovery rates significantly above
the mean and closer to 2.52518 are experiencing an extraordinary
improvement in CD4 T cell counts. This indicates a robust positive
response to the treatment regimen: higher positive recovery rates are
generally associated with better immune system restoration and improved
CD4 T cell counts contribute to enhanced immune function, thus, reducing
susceptibility to opportunistic infections.</p>
<p>Long-term stability in CD4 T cell recovery, as indicated by the
2-year recovery rate, suggests sustained health benefits for these
individuals which is consistent with positive trends over an extended
period and are indicative of the effectiveness of the treatment
protocol.</p>
</div>
<div id="session-info" class="section level1">
<h1>Session info</h1>
<pre><code>## R version 4.3.2 (2023-10-31)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 23.10
## 
## Matrix products: default
## BLAS:   /usr/local/lib/R/lib/libRblas.so 
## LAPACK: /usr/local/lib/R/lib/libRlapack.so;  LAPACK version 3.11.0
## 
## locale:
##  [1] LC_CTYPE=es_ES.UTF-8       LC_NUMERIC=C              
##  [3] LC_TIME=es_ES.UTF-8        LC_COLLATE=C              
##  [5] LC_MONETARY=es_ES.UTF-8    LC_MESSAGES=es_ES.UTF-8   
##  [7] LC_PAPER=es_ES.UTF-8       LC_NAME=C                 
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
## [11] LC_MEASUREMENT=es_ES.UTF-8 LC_IDENTIFICATION=C       
## 
## time zone: America/Mexico_City
## tzcode source: system (glibc)
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
##  [1] viraldomain_0.0.3  broom_1.0.5        ggpubr_0.6.0       factoextra_1.0.7  
##  [5] cowplot_1.1.2      lubridate_1.9.3    forcats_1.0.0      stringr_1.5.1     
##  [9] dplyr_1.1.4        purrr_1.0.2        readr_2.1.4        tidyr_1.3.1       
## [13] tibble_3.2.1       ggplot2_3.5.0      tidyverse_2.0.0    FactoMineR_2.9    
## [17] viruslearner_0.0.2
## 
## loaded via a namespace (and not attached):
##   [1] kknn_1.3.1           sandwich_3.1-0       rlang_1.1.3         
##   [4] magrittr_2.0.3       applicable_0.1.0     multcomp_1.4-25     
##   [7] compiler_4.3.2       mgcv_1.9-0           vctrs_0.6.5         
##  [10] pkgconfig_2.0.3      fastmap_1.1.1        backports_1.4.1     
##  [13] labeling_0.4.3       utf8_1.2.4           rmarkdown_2.25      
##  [16] prodlim_2023.08.28   tzdb_0.4.0           xfun_0.43           
##  [19] cachem_1.0.8         jsonlite_1.8.8       flashClust_1.01-2   
##  [22] recipes_1.0.10       highr_0.10           parallel_4.3.2      
##  [25] cluster_2.1.4        R6_2.5.1             bslib_0.6.1         
##  [28] stringi_1.8.3        parallelly_1.37.1    rpart_4.1.21        
##  [31] car_3.1-2            jquerylib_0.1.4      estimability_1.4.1  
##  [34] Rcpp_1.0.12          knitr_1.45           future.apply_1.11.1 
##  [37] zoo_1.8-12           Matrix_1.6-1.1       splines_4.3.2       
##  [40] nnet_7.3-19          igraph_1.6.0         timechange_0.3.0    
##  [43] tidyselect_1.2.0     rstudioapi_0.15.0    abind_1.4-5         
##  [46] yaml_2.3.8           timeDate_4032.109    vdiffr_1.0.7        
##  [49] codetools_0.2-19     listenv_0.9.1        lattice_0.21-9      
##  [52] withr_3.0.0          evaluate_0.23        future_1.33.1       
##  [55] survival_3.5-7       RcppParallel_5.1.7   pillar_1.9.0        
##  [58] TeachingDemos_2.12   carData_3.0-5        DT_0.31             
##  [61] generics_0.1.3       hms_1.1.3            munsell_0.5.0       
##  [64] scales_1.3.0         globals_0.16.2       plotmo_3.6.2        
##  [67] xtable_1.8-4         leaps_3.1            class_7.3-22        
##  [70] glue_1.7.0           emmeans_1.9.0        scatterplot3d_0.3-44
##  [73] proxyC_0.3.4         tools_4.3.2          data.table_1.15.2   
##  [76] gower_1.0.1          ggsignif_0.6.4       mvtnorm_1.2-4       
##  [79] grid_4.3.2           plotrix_3.8-4        ipred_0.9-14        
##  [82] colorspace_2.1-0     nlme_3.1-163         earth_5.3.2         
##  [85] Formula_1.2-5        cli_3.6.2            workflows_1.1.4     
##  [88] parsnip_1.2.0        fansi_1.0.6          lava_1.8.0          
##  [91] gtable_0.3.4         rstatix_0.7.2        sass_0.4.8          
##  [94] digest_0.6.35        ggrepel_0.9.4        TH.data_1.1-2       
##  [97] htmlwidgets_1.6.4    farver_2.1.1         htmltools_0.5.7     
## [100] lifecycle_1.0.4      hardhat_1.3.1        multcompView_0.1-9  
## [103] MASS_7.3-60</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
